Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
November 3, 2023
DTRF Hosts the 2023 “Together We Will” Weekend in Philadelphia
Read More about DTRF Hosts the 2023 “Together We Will” Weekend in Philadelphia
October 30, 2023
Reflections From Jeanne Whiting, Our Retiring Executive Director And DTRF’s Co-Founder
October 1, 2023
Ten New ICD-10-CM Diagnosis Codes For Desmoid Tumors Go Into Effect on October 1, 2023, in the United States.
September 30, 2023
Desmoid Tumor Awareness Month 2023 Comes To A Close
Read More about Desmoid Tumor Awareness Month 2023 Comes To A Close
September 26, 2023
DTRF Press Release: The Desmoid Tumor Research Foundation Announces That Groundbreaking Results From The Phase 3 Springworks Defi Trial Were Published Today In The New England Journal Of Medicine (More)
June 12, 2023
Coverage of Desmoid Tumors at ASCO 2023
May 21, 2023
Top 5 Reasons To Attend The Annual DTRF Together We Will Weekend
Read More about Top 5 Reasons To Attend The Annual DTRF Together We Will Weekend
May 9, 2023
NCI Article, “Nirogacestat May Offer Hope To People With Desmoid Tumors”
Read More about NCI Article, “Nirogacestat May Offer Hope To People With Desmoid Tumors”
April 3, 2023
What’s New with the DTRF Together We Will Weekend?
Read More about What’s New with the DTRF Together We Will Weekend?
March 7, 2023
DTRF Announces The First Publicly Available Desmoid Tumor Immortal Cell Line
Read More about DTRF Announces The First Publicly Available Desmoid Tumor Immortal Cell Line
February 27, 2023
Update: Springworks Therapeutics Has Announced FDA acceptance And Priority Review Of The New Drug Application For Nirogacestat
Clinical Trials December 27, 2022
Breaking News: Springworks Therapeutics Announces Submission Of New Drug Application For Nirogacestat To The U.S. FDA
November 22, 2022
Desmoid Tumors In The Spotlight At The 2022 Connective Tissue Oncology Society (CTOS) Conference
October 27, 2022
DTRF And PeerView Offer CME Accredited Course At CTOS On Treatment Of Desmoid Tumors
Read More about DTRF And PeerView Offer CME Accredited Course At CTOS On Treatment Of Desmoid Tumors
October 20, 2022
DTRF Exec. Dir. Presents At CTOS Webinar On Desmoid Tumors, The CTOS 2022 “Sarcoma Of The Year”
Research 
September 30, 2022
Desmoid Tumor Awareness Month 2022 Comes To A Close
Read More about Desmoid Tumor Awareness Month 2022 Comes To A Close
September 27, 2022
DTRF Hosts Successful 2022 Virtual DTRF “Together We Will” Weekend
Read More about DTRF Hosts Successful 2022 Virtual DTRF “Together We Will” Weekend
Clinical Trials September 13, 2022
